Jan 09, 2024 / 05:45PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst
Hi, I'm Robbie Marcus, I'm the medtech analyst at JPMorgan. Really happy to introduce our next speaker, Jim Hollingshead from Insulet, the CEO. Jim, let you do the presentation, then I'll come up on stage. We'll do a little Q&A.
James R. Hollingshead - Insulet Corporation - President, CEO & Director
Perfect. Good morning, everybody. Thank you, Robbie, and thanks for the opportunity. Glad to have the opportunity to talk with you all the day and glad you're all here. So thank you for coming. I want to start by introducing you to Kimsue here on our cover page. Kimsue is a digital creator. She's a stylist and an influencer and she was diagnosed with Type 1 diabetes more than a decade ago. And she's been using Omnipod 5, our flagship product since last year, just in the last year.
And Kimsue loves this product. She tells us she's very active. She's doing things all the time. And what she tells us is that Omnipod 5 allows people with Type 1 diabetes to fly like she does. And
Insulet Corp at JPMorgan Healthcare Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers